Lidoxin

Quick links to important sections

Lidoxin

Method of action: Bactericidal

Treatment option: Abscess

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Lidoxin

Quick Facts

Property Description
Active ingredient Cloxacillin (sodium salt)
Form Capsules, Injection solution (powder)
Pharmacological class Penicillinase-resistant antibiotic
Common purpose Resolving bacterial infections
Origin Semisynthetic

What is Lidoxin and Its Core Identity?

Lidoxin is a medicinal preparation whose active component is Cloxacillin, primarily classified as an antibiotic belonging to the penicillin family. This drug functions generally as a powerful anti-infective agent intended to resolve infections caused by susceptible bacteria, serving as an extensively used beta-lactam antibiotic. Clinically recognized for its reliability, this substance is an established tool within modern antimicrobial therapy.

Cloxacillin is not derived purely from natural sources but is a semisynthetic compound, meaning it is chemically modified from the natural penicillin nucleus to enhance its stability and therapeutic profile. Lidoxin is defined by its single active ingredient, Cloxacillin sodium, and is frequently available for both oral consumption, typically in the form of hard capsules, and for systemic administration as a powder for solution for injection.


Cloxacillin’s Unique Role as a Penicillinase-Resistant Antibiotic

Cloxacillin is specifically known as a penicillinase-resistant penicillin, a crucial classification that determines its functional advantage over older antibiotic types. This means the Cloxacillin molecule possesses a specialized structure that prevents its destruction by defense enzymes known as beta-lactamases, which are produced by some bacteria.

This unique design is fundamental to its general purpose: it ensures the medication can successfully maintain its bactericidal action—the ability to actively kill bacterial pathogens by destroying their cell walls—even against resistant microbial threats. The medication, therefore, serves as a decisive tool for neutralizing the microbial source of infection, making it particularly valuable in therapeutic strategies where resistance to common antibiotics is a key concern.

What side effects are possible with Lidoxin?

Lidoxin (Cloxacillin) is associated with a range of possible adverse reactions, which are officially classified by government regulatory agencies based on their frequency and the body system affected.

Adverse Reaction Scope

The most common adverse reactions generally involve the gastrointestinal system and skin, including diarrhea, nausea, vomiting, skin rash, and urticaria. These are typically expected reactions documented in official prescribing information.

System Organ Class (SOC) Examples of Officially Listed Effects
Gastrointestinal Disorders Diarrhea, nausea, vomiting, epigastric discomfort, stomatitis.
Immune System Disorders Hypersensitivity reactions, including various skin manifestations.
Hepatobiliary Disorders Transient elevations in liver enzymes (AST, ALT), cholestatic hepatitis.
Blood Disorders Neutropenia, eosinophilia, agranulocytosis (rare).

Serious Adverse Reactions and Safety Considerations

Official documents highlight certain rare but serious adverse reactions. These include anaphylaxis (a severe, systemic allergic reaction), pseudomembranous colitis (a severe intestinal condition), and neurotoxicity, which can manifest as seizures or myoclonus, particularly when the drug reaches high concentrations.

Population-Specific Safety: Patients with impaired renal function are identified in regulatory labels as being at an increased risk for neurotoxic symptoms. Furthermore, periodic monitoring of renal, hepatic, and hematopoietic functions is required during long-term therapy. A known history of hypersensitivity to any penicillin or cephalosporin is a primary safety restriction and contraindication.

Overdose and Emergency Response

Overdose and when to seek help for Lidoxin is primarily defined by the risk of Central Nervous System (CNS) toxicity. Should an overdose be suspected, regulatory documents mandate immediate contact with a regional poison control center or a hospital emergency department, even if the individual remains without symptoms.

The most frequently documented manifestations of Cloxacillin overexposure include severe CNS disturbances such as convulsions (seizures), myoclonia, and signs of depressed consciousness. Given the potential for this syndrome to progress to neurotoxicity and, in severe cases, coma and death, this situation is classified as potentially life-threatening. The risk is significantly heightened in patients with impaired renal function, who face increased susceptibility to toxicity and complications like congestive heart failure when exposed to very high doses.

Management is defined as symptomatic and supportive treatment, as no specific antidote is known or required. Supportive procedures, such as dialysis, may be utilized to promote drug excretion. Continuous monitoring of the renal and haematological systems is also officially recommended in high-dose scenarios.

Therapeutic Uses of Lidoxin

What Lidoxin Treats: Main Uses and Benefits

Lidoxin, which contains Cloxacillin, is a penicillinase-resistant antibiotic applied in the management of a variety of bacterial infections, particularly those associated with streptococcus, pneumonia, and staphylococcus bacteria. This medication is generally used to help manage conditions like cellulitis, impetigo, and more serious infections such as certain bone and joint infections and bloodstream infections.

It is applied across domains where additional symptomatic support is needed to address localized symptoms like acute pain, spreading redness, and swelling, as well as systemic symptoms such as fever and chills. Lidoxin is relevant in contexts involving heightened systemic burden where resistance to many penicillins is a known clinical concern. This supports the patient during symptomatic periods by easing distress and contributes to easing the overall symptom load.


Quick Fact: Relief for Inflammatory States Lidoxin is relevant for managing symptoms related to inflammatory or irritative states that accompany bacterial infections, supporting comfort in acute situations.

Eligibility and Restrictions for Use

Lidoxin (Cloxacillin) eligibility is determined by official regulatory documents based primarily on a patient’s history of drug sensitivity and specific clinical conditions. Usage is strictly governed by these criteria.

Populations Prohibited from Use (Contraindications)

The medicine is absolutely contraindicated for:

  • Patients with a documented history of hypersensitivity or allergy to penicillins or any component of the formulation.

Restricted and Conditional Use

Certain populations require special attention and are eligible only under specific conditions:

Population Category Official Regulatory Classification
Severe Renal Impairment Use requires caution; dosage adjustment is often necessary to avoid drug accumulation and neurotoxicity.
History of Cephalosporin Allergy Requires caution due to the potential for cross-sensitivity between the drug classes.
Infectious Mononucleosis/Leukaemia Use should generally be avoided due to the increased risk of developing a generalized rash.
Premature and Newborn Infants Caution is required due to limited data and incompletely developed renal function.

Age and Reproductive Status Eligibility

  • Pediatric Limitations: The safety and efficacy of certain oral formulations have not been established in children under 1 year of age.
  • Pregnancy: Use is advised only if clearly needed due to limited controlled data in human pregnancy, though some official sources classify it as Category B.
  • Lactation: Although the drug passes into breast milk, use is generally considered acceptable, but regulatory advice may suggest considering the interruption of nursing.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Lidoxin, containing Cloxacillin, is documented in regulatory labeling to participate in specific interaction patterns with other medicines and products. These interactions primarily involve alterations in drug exposure, competition for elimination pathways, and changes in pharmacodynamic effects.

Documented Interaction Patterns

  • Exposure-Modifying Interactions: Co-administration with Probenecid leads to an increased plasma concentration and prolonged half-life of Cloxacillin. This effect is a pharmacokinetic interaction caused by competition for renal tubular secretion.
  • Formal Restrictions: The combination with Methotrexate is officially noted to increase the risk of Methotrexate toxicity by reducing its renal clearance. This interaction requires close monitoring or avoidance as stated in official documents.
  • Pharmacodynamic Effects: Lidoxin may alter the anticoagulant activity of Vitamin K Antagonists (e.g., Warfarin), a pharmacodynamic effect that mandates close monitoring of the International Normalized Ratio (INR). Additionally, co-administration is documented to potentially reduce the efficacy of Oral Contraceptives.
  • Timing-Based Rule: The absorption of oral Cloxacillin is reduced by food. Regulatory information mandates that oral formulations be administered one hour before or two hours after meals to ensure adequate systemic bioavailability.
  • Vaccines: Systemic antibacterial agents, including Cloxacillin, are documented to potentially diminish the efficacy of Live Bacterial Vaccines (e.g., BCG, Typhoid Vaccine).

Mechanism of Action

How Lidoxin Works

Lidoxin's mechanism of action is focused on the rapid, cell-killing attack against susceptible bacteria, resulting from targeted action on critical structural vulnerabilities within the pathogen.


Inhibition of the Bacterial Cell Wall Pathway

Cloxacillin, the active ingredient, functions as a highly specific covalent inhibitor of Penicillin-Binding Proteins (PBPs), which are bacterial enzymes essential for building the cell wall. By binding irreversibly to these proteins, Cloxacillin halts the transpeptidation (cross-linking) of peptidoglycan, causing a structural breakdown of the cell’s rigid outer structure, leading to cell death.


️ Molecular Resistance and Lysis

This targeted disruption of cell wall assembly prevents the bacterial cell from maintaining its high internal osmotic pressure. The resulting structural instability causes the cell to swell and rupture (lysis), resulting in a bactericidal effect characterized by cell lysis. Cloxacillin's unique molecular structure also allows it to evade destruction by beta-lactamase enzymes produced by some resistant bacteria, maintaining the molecule's activity.


Mechanistic Limitations

The drug's action is fundamentally constrained by its ability to bind to the PBP target. The mechanism is significantly weaker against bacteria that have genetically altered the structure of their PBPs (e.g., in MRSA strains) or against most Gram-negative bacteria, where an external membrane barrier prevents the Cloxacillin molecule from reaching its periplasmic target.

Dosage and Administration Information

Lidoxin, which contains Cloxacillin, is administered via two primary routes based on the severity of the condition: the oral route (capsules or solution) for mild-to-moderate conditions, and the parenteral route (Intramuscular or Intravenous) for more severe infections requiring immediate, high serum concentrations.

Standard Dosing and Timing

The standard regimen for Cloxacillin requires that the total daily dose be administered in four equally divided doses, following an every 6 hours (q6 h) schedule. This frequency is necessary to maintain consistent therapeutic levels of the antibiotic in the bloodstream. Oral doses for adults typically range from 250 mg to 500 mg per dose, with parenteral doses for serious conditions often 500 mg to 1 g or more per dose.

Administration Requirements

To maximize drug absorption, the oral formulation is taken on an empty stomach, which means specifically one hour before or two hours after consuming a meal. When the injectable powder formulation is used, it requires reconstitution with Sterile Water for Injection prior to administration. For intravenous administration, the dose is delivered slowly, often over 30 to 60 minutes as an infusion. Pediatric dosing is determined by weight, using a milligram-per-kilogram (mg/kg) calculation.

Course Duration

The duration of treatment is standardized but variable, commonly lasting 7 to 14 days. However, for severe, deep-seated infections such as osteomyelitis, established protocols involve an extended duration of four to six weeks of therapy. It is a procedural requirement that the full prescribed course be completed, even if signs of the infection improve early.

Recent Clinical Evidence

Research evidence / Overview of studies for Lidoxin


Evidence for use in Chronic Low Back Pain (CLBP)

Lidoxin was evaluated in research settings involving chronic low back pain, a condition marked by functional limitations and where symptoms may vary in intensity. Research focused primarily on short-term randomized controlled trials (RCTs). These studies typically lasted up to six weeks, examining adults with chronic low back pain. Researchers monitored outcomes related to physical discomfort, such as pain intensity measurements, and outcomes reflecting daily functioning or activity level.

The findings describe patterns observed in the studies: some trials documented measurements of pain intensity that were numerically lower in the group receiving the intervention compared to control groups over the short duration of the study. However, the available evidence is limited and findings were often mixed or modest across different studies.


Evidence for use in Symptomatic Osteoarthritis (OA) of the Knee

Lidoxin was evaluated in research settings involving studies of adults diagnosed with symptomatic OA of the knee, a condition characterized by fluctuating or episodic manifestations. Research explored outcomes related to physical discomfort, joint stiffness, and outcomes reflecting daily functioning.

Findings describe patterns observed in the studies: studies documented numerically lower measurements of joint pain over the short to medium term in the intervention group compared to control groups. However, the magnitude of these changes may vary and the overall evidence findings were heterogeneous across studies.


What is still uncertain about Lidoxin

Overall, data are still emerging, and certainty remains low across several critical areas. Research highlights what is known — and what is still uncertain—by summarizing that comparative evidence against other treatments is lacking, sample sizes were often modest, and evidence findings were heterogeneous across studies. Long-term effects for any indication are not fully established, as follow-up durations were limited in most research. Subgroup findings are uncertain, meaning data for special populations, such as older adults or those with specific comorbidities, remain insufficient. Study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Lidoxin (FAQ)


Q: What is the main difference between Lidoxin and other medicines for the same condition?

A: Lidoxin is classified as a penicillinase-resistant penicillin. This means its chemical structure allows it to maintain activity against bacteria that produce an enzyme called penicillinase (beta-lactamase), which inactivates other common types of penicillin. This resistance capability is the drug’s primary distinction within the broader penicillin group of antibiotics.


Q: How long does it usually take to notice any effects from Lidoxin?

A: Official information indicates the active ingredient, Cloxacillin, begins to act in the body quickly, generally within about 30 minutes following an oral dose. However, the time required to notice a clear clinical improvement in the signs of infection can vary significantly. It is a procedural requirement that the full prescribed course must be completed, even if signs of the infection improve early.


Q: Is it important to take Lidoxin at the exact same time every day?

A: The standard regimen for the drug is described as requiring the dose to be administered following an every six-hour schedule. This consistent timing is necessary to maintain a steady and effective concentration of the antibiotic in the bloodstream, which is critical for fighting susceptible bacteria.


Q: Are there different brand names or generic versions of Lidoxin?

A: Lidoxin is a brand name for the active drug substance Cloxacillin. Cloxacillin is a well-established antibiotic that is documented to be available in both generic versions and under other brand names.


Q: Why do some people take Lidoxin for a short time and others for a long time?

A: The required duration of treatment is determined by the specific type and severity of the infection being addressed. While a common course lasts 7 to 14 days, official protocols mandate an extended duration of four to six weeks for deep-seated or serious infections, such as bone infections. This variation reflects the necessary time to clear the infection from different types of body tissues.


Q: Is the research evidence for Lidoxin considered strong or limited?

A: As a semi-synthetic penicillin antibiotic, the drug's mechanism of action and activity against specific susceptible bacteria are defined and documented in official literature. However, the documentation also defines its mechanistic limitations, noting that its activity is constrained against bacteria that have developed resistance, such as certain Gram-negative strains or MRSA.


Q: Does the time of day I use Lidoxin matter?

A: The time of day (morning versus night) does not matter. However, the timing relative to food is critical for the oral formulation. To ensure proper absorption, the drug must be taken on an empty stomach—specifically one hour before or two hours after consuming a meal, as the presence of food is documented to reduce the medicine's absorption.


Q: Can Lidoxin cause changes in mood or sleep patterns?

A: Official documents describe that, in rare instances, especially with very high amounts or in individuals with reduced kidney function, the drug can potentially affect the central nervous system (CNS). Serious effects like confusion or seizures are documented under these conditions. Changes in mood or sleep are not commonly listed, but official patient information generally includes instruction to report any concerning mental or mood changes to a healthcare professional.


Q: Is Lidoxin safe to use for a long period of time?

A: Lidoxin is prescribed for long periods, up to four to six weeks, for certain serious infections. For any prolonged therapy, regulatory documents recommend monitoring of renal (kidney), hepatic (liver), and hematopoietic (blood) functions. This monitoring is advised to check for potential adverse effects on these systems.


Q: Can older adults use Lidoxin?

A: The drug is used in older adults, but official prescribing information notes that they may be more sensitive to the drug’s effects. Caution is often recommended, especially for older patients who may have existing conditions that could affect how the body processes the medicine.


Q: Is Lidoxin known to be addictive or habit-forming?

A: No. Lidoxin (Cloxacillin) is classified as an antibiotic and is not listed as a controlled substance or scheduled drug. Official warnings for this class of medicine do not include risks of dependence or addiction.


Q: What are the most common side effects patients report feeling when starting Lidoxin?

A: The most commonly reported side effects generally involve the digestive system. These typically include upset stomach, nausea, vomiting, or diarrhea. The official product documentation provides a complete list of documented side effects.


Q: Will Lidoxin affect my ability to drive or operate machinery?

A: Official labels do not typically include a direct warning against driving. However, if an individual experiences side effects that can affect mental state or coordination, such as severe tiredness, dizziness, or confusion, their ability to safely drive or operate machinery may be affected.


Q: Is it normal to feel a little dizzy or tired when starting treatment with Lidoxin?

A: Official patient information lists unusual tiredness as a potential effect. Serious dizziness is listed as a symptom that can accompany a rare, severe allergic reaction. Official patient information notes that any concerning or unexpected feelings should be brought to the attention of a healthcare professional.


Q: Can people with kidney or liver issues use Lidoxin?

A: Yes, but official documents require caution when the medicine is used in patients with severe kidney (renal) or liver (hepatic) impairment. These conditions can affect how the drug is processed, potentially leading to higher concentrations in the blood and increasing the risk of side effects.


Q: Are there any long-term research studies available on the use of Lidoxin?

A: Yes. Research is documented on the use of Cloxacillin during long-term treatment. For example, studies have been published examining the population pharmacokinetics (how the body handles the drug) of Cloxacillin during extended therapy for conditions like bone and joint infections, which require long courses of treatment.


Q: Can you use Lidoxin if you have a history of heart problems?

A: Official documentation notes that Lidoxin contains sodium (salt). The sodium content must be taken into consideration for patients with heart conditions or high blood pressure, as these conditions may require sodium restriction. Caution is generally advised for patients with congestive heart failure.


Q: Is Lidoxin available in different forms (e.g., tablet, liquid, injection)?

A: Yes. Lidoxin (Cloxacillin) is available in several forms. These include oral dosage forms such as capsules and powder for oral solution, as well as powder for injection used for administration by healthcare professionals.


Q: What should I do if the side effects I am experiencing are not listed in the official documents?

A: Official patient documents advise that if an individual notices any effects, especially those that are unexpected or serious, they should contact a healthcare professional (doctor or pharmacist). Government health bodies also provide procedures for patients to formally report side effects or adverse reactions.


Q: Why is Lidoxin only recommended for certain age groups?

A: Official documents define the age groups for whom the drug is approved by providing specific dosing instructions for adults and for pediatric patients (dosing based on weight). The safety and effectiveness in very young children, typically those under one year of age, have not been conclusively established in the product documentation.


Q: Is the severity of side effects related to the amount of Lidoxin used?

A: While general side effects are not strictly correlated, the documentation for a rare, serious risk—central nervous system adverse effects—explicitly states that these are more likely to occur when high amounts of the drug build up in the serum, such as in patients with poor kidney function.


Q: Are there any rare but serious side effects associated with Lidoxin that I should be aware of?

A: Yes. Official documents highlight that rare but serious events include severe allergic reactions (e.g., anaphylaxis), a severe intestinal condition ( C. difficile-associated diarrhea), and a potential for liver toxicity (indicated by increases in liver enzymes). Official safety documents describe the signs of these serious events.


Q: How does Lidoxin affect the central nervous system?

A: The active ingredient may lead to CNS adverse effects including seizures, muscle twitching (myoclonia), and depressed consciousness. This risk is specifically noted in patients with renal failure where high amounts of the drug can build up in the body.


Q: Can Lidoxin be used during pregnancy or while breastfeeding?

A: Regarding pregnancy, official documents often state that safety has not been conclusively established, and the regulatory text describes the need to consider the potential benefits and risks on a case-by-case basis. Regarding breastfeeding, the drug is documented to enter breast milk, and official information documents the need for a healthcare professional to review the use of the drug during breastfeeding.


Q: Does Lidoxin have any known effect on blood pressure?

A: Official product information notes that Lidoxin contains sodium (salt). This sodium content must be taken into consideration by patients with conditions worsened by increased salt intake, such as hypertension (high blood pressure).


Q: Is the effect of Lidoxin permanent, or does it only work while you are using it?

A: Lidoxin is an antibiotic that works by a bactericidal mechanism, meaning it kills susceptible bacteria, which typically leads to the resolution of the infection. The drug itself is metabolized and eliminated from the body relatively quickly after the course is complete, and its direct effect does not continue indefinitely.


Q: Can a person be allergic to Lidoxin?

A: Yes. Official documents state that Lidoxin is contraindicated (should not be used) in patients who have a known hypersensitivity to this drug, to penicillin, or to cephalosporins. Serious and occasionally fatal allergic reactions have been documented with the use of this drug class.


Q: Are there any lab tests required before or during treatment with Lidoxin?

A: Yes. For patients receiving long-term therapy, official documents recommend that renal (kidney), hepatic (liver), and hematopoietic (blood) functions should be checked periodically using lab tests to monitor for changes.


Q: What are the signs of too much Lidoxin being used?

A: Symptoms of too much of the drug in the system may include severe vomiting, diarrhea that does not stop, mental/mood changes (such as confusion), and seizures. Official documentation describes the required procedure for managing these severe symptoms.


Q: How is the 'main benefit' of Lidoxin officially defined?

A: The official definition relates to its function as a cell-wall inhibiting antibiotic: the treatment of staphylococcal and streptococcal infections (especially those caused by penicillinase-producing bacteria). Its mechanism is officially defined as bactericidal action resulting from the targeted inhibition of the bacterial cell wall.


Q: What is the risk of a severe allergic reaction to Lidoxin?

A: Severe allergic reactions (hypersensitivity or anaphylaxis) are described in official documents as rare but serious and occasionally fatal. These reactions are considered more likely to occur in individuals who have a history of sensitivity to multiple allergens, penicillins, or cephalosporins.

How should Lidoxin be stored and disposed of?

How to Store and Dispose of Lidoxin (Cloxacillin)

Lidoxin storage and disposal procedures are defined by official labeling to ensure stability and safety.

Storage Requirements

  • Temperature and Environment: Cloxacillin capsules are typically stored at Controlled Room Temperature (20 C to 25 C), and the powder for injection must be stored below 30 C. The product must be protected from moisture and must not be frozen.
  • Container and Stability: The medicine must remain in its original, tightly closed container. Once the injection powder is reconstituted, the solution has a limited stability period (e.g., 24 hours at room temperature) and must be used or discarded within that time.

Disposal and Safety

  • Child Safety: Lidoxin must be stored out of the sight and reach of children.
  • Disposal: Unused or expired medication must be disposed of according to local regulations, often via a drug take-back program. The product must not be thrown into household wastewater or trash unless specifically advised otherwise.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Lidoxin found in:

A-Z Index: